Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy (Q40269064)

19 September 2017

title

Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy (English)

1 reference

19 September 2017

Akira Mima

1

1 reference

19 September 2017

Takeshi Matsubara

2

1 reference

19 September 2017

Hidenori Arai

3

1 reference

19 September 2017

Hideharu Abe

4

1 reference

19 September 2017

Kojiro Nagai

5

1 reference

19 September 2017

Hiroshi Kanamori

6

1 reference

19 September 2017

Eriko Sumi

7

1 reference

19 September 2017

Toshikazu Takahashi

8

1 reference

19 September 2017

Noriyuki Iehara

9

1 reference

19 September 2017

Atsushi Fukatsu

10

1 reference

19 September 2017

Toru Kita

11

1 reference

19 September 2017

Toshio Doi

12

1 reference

19 September 2017

publication date

12 June 2006

1 reference

19 September 2017

published in

Laboratory Investigation

1 reference

19 September 2017

volume

86

1 reference

19 September 2017

issue

9

1 reference

19 September 2017

page(s)

927-939

1 reference

Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

The extracellular matrix in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Glomerular actions of angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Src is required for cell migration and shape changes induced by fibroblast growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

A multifunctional transcription factor (A1p145) regulates the smooth muscle phenotype in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

Enhanced expression of "muscle-specific" actin in glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Diabetic nephropathy: it's in the numbers

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Up-regulation of extracellular matrix proteoglycans and collagen type I in human crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

A vitamin D analog regulates mesangial cell smooth muscle phenotypes in a transforming growth factor-beta type II receptor-mediated manner

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Transforming growth factor-beta and the pathogenesis of glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700445

7 January 2021

10.1038/LABINVEST.3700445

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1049298029

0 references

1 reference